We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Delivering Cancer Medication Safely to Its Destination

News   Aug 09, 2019 | Original story from Leibniz-Forschungsinstitut für Molekulare Pharmakologie

 
Delivering Cancer Medication Safely to Its Destination

The new technology enables a simple way of connecting the cytsteine residues (SH) of a tumor-sensing antibody (yellow) to toxic drug molecules. The emerging linker is highly stable during blood circulation and enables therefore a safe transport to the tumor side. Credit: Barth van Rossum/FMP

 
 
 

RELATED ARTICLES

Discovery of How Cells Override Genetic Changes Could Advance Pancreatic Cancer Treatment

News

A discovery by scientists at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) could lead researchers to a more effective way to treat pancreatic cancer.

READ MORE

More Cancer Cases Amongst Women With Sleep Apnea

News

Women suffering from severe sleep apnea appear to be at an elevated risk of getting cancer, according to a new study.

READ MORE

Ebola Patients Have a 90% Survival Rate After Injection With New Drugs

News

Two Ebola drugs have proven so effective in a clinical trial that researchers will make the treatments available to anyone infected with the virus in the Democratic Republic of the Congo, where Ebola has killed nearly 1,900 people over the past year.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE